Sort by
Refine Your Search
-
Postdoctoral Researcher (Physicist, Chemist or Material Scientist( (all genders) for a Tenure Tra...
: Online-Bewerbungsportal GSI Helmholtzzentrum für Schwerionenforschung GmbH ABTEILUNG PERSONAL PLANCKSTRASSE 1 64291 DARMSTADT This research center is part of the Helmholtz Association of German Research
-
Research. The focus is on evaluating and selecting the most promising HCV vaccine candidate for clinical translation, based on rigorous benchmarks of efficacy, safety, and feasibility. Your Role: As part of
-
Postdoctoral Researcher (m/f/d) for the research project “Protein Regulation in Cancer”Starting from August 1, 2025, full-time or part-time, limited to 2 years with the option for extensionKlinik
-
Autumn 2025 or upon agreement. We offer a part-time position (65%, 26 hours per week), offered as a fixed-term position for 3.5 years. Most fungal pathogens that infect humans originate from
-
| Full-time/Part-time | Remote work possible DESY, with more than 2900 employees at its two locations in Hamburg and Zeuthen, is one of the world's leading research centres. Its research focuses
-
, employing advanced statistical methods and cutting-edge artificial intelligence techniques to uncover novel insights into these complex interactions. As part of this position, you will have the opportunity
-
! The Clinic focuses on inflammatory diseases of the central nervous system, especially multiple sclerosis. As part of the Department of Neurology, we study the pathogenesis and treatment of this and other
-
Postdoctoral researcher (m/f/d) – Medical Department for Hematology, Oncology, and Cell Therapy The Faculty of Medicine is an integral part of the Otto-von-Guericke-University Magdeburg and
-
conducted at the existing GSI facility as part of FAIR Phase-0, using the Fragment Separator (FRS). Exotic isotopes are identified on an event-by-event basis and implanted into the core of the DESPEC array
-
. The postdoctoral position is part of the Carl Zeiss Foundation-funded “ImmuneMPS” consortium, which aims to develop microphysiological systems to advance understanding of cancer–immune interactions. The consortium